As GLP-1 drugs like Ozempic and Wegovy become more common, emerging research and patient reports raise a surprising question: are these medications changing how people move? While the drugs often deliver rapid weight loss and metabolic gains, many patients report doing less formal exercise. That pattern has public health experts …